AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease

RecruitingPhase 1Ages 50 Years - 85 YearsAllKeymed Biosciences Co.Ltd
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is a randomized, double-blind, placebo-controlled and multiple dose escalation phase Ib study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of CM383 in patients with Alzheimer's disease related mild cognitive impairment and mild Alzheimer's disease.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Voluntarily participate and have the subject and their legal guardian jointly sign the Informed Consent Form. * The age of the subjects is between 50 and 85 years old. * BMIโ‰ฅ19kg/m2 and โ‰ค32.5 kg/m2, weight โ‰ฅ45 kg and โ‰ค100 kg at screening or baseline. Exclusion Criteria: * Cognitive impairment of subjects due to other medical or neurological factors (other than AD) * History of stroke or transient ischemic attack, seizures, or other unexplained loss of consciousness within the past year * With any mental illness that may interfere with the cognitive assessment of the subjects. * With history of moderate or severe renal dysfunction. * With Uncontrolled stable hypertension. * With history of severe trauma or major surgery in the 6 months prior to the screening period, or planned surgery during the study. * History of malignancy within 5 years prior to screening.
๐Ÿ’Š

What it tests

  • Alzheimer Disease (AD)
  • Placebo
๐Ÿ“

Where

1 site
The First Affiliated Hospital of University of Science and Technology of China
Hefei, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy